切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2019, Vol. 13 ›› Issue (05) : 389 -392. doi: 10.3877/cma.j.issn.1674-0793.2019.05.013

所属专题: 文献

论著

内镜下黏膜切除术及黏膜剥离术治疗早期胃癌和癌前病变的疗效对比研究
周宏1,(), 谈春晓1, 夏加增1   
  1. 1. 214000 无锡市第二人民医院普外科
  • 收稿日期:2018-08-20 出版日期:2019-10-01
  • 通信作者: 周宏

Comparison of the efficacy of endoscopic mucosal resection and endoscopic submucosal dissection in thetreatment of early gastric cancer and precancerous lesions

Hong Zhou1,(), Chunxiao Tan1, Jiazeng Xia1   

  1. 1. Department of General Surgery, Wuxi Second People’s Hospital, Wuxi 214000, China
  • Received:2018-08-20 Published:2019-10-01
  • Corresponding author: Hong Zhou
  • About author:
    Corresponding author: Zhou Hong, Email:
引用本文:

周宏, 谈春晓, 夏加增. 内镜下黏膜切除术及黏膜剥离术治疗早期胃癌和癌前病变的疗效对比研究[J/OL]. 中华普通外科学文献(电子版), 2019, 13(05): 389-392.

Hong Zhou, Chunxiao Tan, Jiazeng Xia. Comparison of the efficacy of endoscopic mucosal resection and endoscopic submucosal dissection in thetreatment of early gastric cancer and precancerous lesions[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2019, 13(05): 389-392.

目的

对比分析内镜下黏膜切除术(EMR)和内镜下黏膜剥离术(ESD)对治疗早期胃癌(EGC)和癌前病变的效果和安全性。

方法

选取2015年1月至2016年1月无锡市第二人民医院收治的60例EGC和癌前病变患者为研究对象,根据治疗方式分为EMR组(32例)和ESD组(28例),对比分析两组患者的手术时间、禁饮禁食时间、术中出血情况、术后病理、整块切除率、治愈性切除率、肿瘤局部复发率、肿瘤残留率和术中、术后不良反应及预后情况。

结果

ESD组患者手术时间长于EMR组[(53.35±7.12)min vs(34.23±5.74)min,t=2.009,P=0.043],术中出血量多于EMR组[(10.26±3.42)ml vs(3.35±0.71)ml,t=2.511,P=0.018],差异有统计学意义。ESD组患者病灶整块切除率(92.9% vs 62.5%,χ2=7.693,P=0.006)及治愈性切除率(78.6% vs 43.8%,χ2=7.545,P=0.006)均高于EMR组患者,差异有统计学意义。ESD组不良反应率为14.3%(4/28),高于EMR组的3.1%(1/32),差异有统计学意义(χ2=8.765,P=0.001)。两组患者术后2年总生存率比较,差异无统计学意义(χ2=0.643,P=0.423)。

结论

与EMR相比,ESD可能是治疗EGC及癌前病变的一种较为安全有效的手术方式。

Objective

To compare the efficacy and safety of endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) in the treatment of early gastric cancer (EGC) and precancerous lesions.

Methods

From January 2015 to January 2016, sixty patients with EGC and precancerous lesions admitted to Wuxi Second People’s Hospital were divided into EMR group (32 cases) and ESD group (28 cases). The operative time and dietary restriction, intraoperative hemorrhage, postoperative pathology, the rate of total excision, curative resection, local recurrence, tumor residual, intraoperative and postoperative adverse reactions and the prognosis between the two groups were compared and analyzed.

Results

The operation time of ESD group was longer than that of EMR group [(53.35±7.12) min vs (34.23±5.74) min,t=2.009, P=0.043], the intraoperative blood loss was more than that of EMR group, with statistically significant differences [(10.26±3.42) ml vs (3.35±0.71) ml, t=2.511, P=0.018]. The total excision rate and curative resection rate of lesions in ESD group were significantly higher than those in EMR group (92.9% vs 62.5%, χ2=7.693, P=0.006; 78.6% vs 43.8%, χ2=7.545, P=0.006). The adverse reaction rate of ESD group was 14.3% (4/28), higher than that of EMR group 3.1% (1/32), and the difference was statistically significant (χ2=8.765, P=0.001). There was no significant difference in the 2-year overall survival rate between the two groups (χ2=0.643, P=0.423).

Conclusion

Compared with EMR, ESD may be a safe and effective surgical procedure for the treatment of EGC and precancerous lesions.

表1 两组早期胃癌和癌前病变患者的基本资料比较
表2 两组早期胃癌和癌前病变患者手术情况及术后病理比较
表3 两组早期胃癌和癌前病变患者治疗效果比较[例(%)]
[1]
廖专,孙涛,吴浩,等. 中国早期胃癌筛查及内镜诊治共识意见(2014年4月·长沙)[J]. 胃肠病学, 2014, 19(7): 408-427.
[2]
Zhou Y, Li XB. Endoscopic prediction of tumor margin and invasive depth in early gastric cancer[J]. J Dig Dis, 2015, 16(6): 303-310.
[3]
杜奕奇,蔡全才,廖专,等. 中国早期胃癌筛查流程专家共识意见(草案)(2017年,上海)[J]. 胃肠病学, 2018, 23(2): 92-97.
[4]
Min YW, Min BH, Lee JH, et al. Endoscopic treatment for early gastric cancer[J]. World J Gastroenterol, 2014, 20(16): 4566-4573.
[5]
王海涛,沈颖洲,宋汉明,等. 内镜下黏膜切除术及剥离术在早期消化道肿瘤中的应用[J]. 安徽医药, 2016, 20(10): 1905-1907,1908.
[6]
El-Sedfy A, Brar SS, Coburn NG. Current role of minimally invasive approaches in the treatment of early gastric cancer[J]. World J Gastroenterol, 2014, 20(14): 3880-3888.
[7]
Sugano K. Detection and management of early gastric cancer[J]. Curr Treat Options Gastroenterol, 2015, 13(4): 398-408.
[8]
陕飞,李子禹,张连海,等. 国际抗癌联盟及美国肿瘤联合会胃癌TNM分期系统(第8版)简介及解读[J]. 中国实用外科杂志, 2017, 37(1): 15-17.
[9]
白顺滟,肖思洁,吴俊超,等. 内镜黏膜下剥离术和黏膜切除术治疗早期胃癌的临床对比分析[J]. 中国内镜杂志, 2014, 20(8): 873-877.
[10]
Gotoda T, Jung HY. Endoscopic resection (endoscopic mucosal resection/endoscopic submucosal dissection) for early gastric cancer[J]. Dig Endosc, 2013, 25(Suppl 1): 55-63.
[11]
Facciorusso A, Antonino M, Di MM, et al. Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer: A meta-analysis[J]. World J Gastrointest Endosc, 2014, 6(11): 555-563.
[12]
Zhao Y, Wang C. Long-term clinical efficacy and perioperative safety of endoscopic submucosal dissection versus endoscopic mucosal resection for early gastric cancer: an updated Meta-analysis[J]. Biomed Res Int, 2018, 2018: 3152346.
[13]
Ono H, Yao K, Fujishiro M, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer[J]. Dig Endosc, 2016, 28(1): 3-15.
[14]
Tanabe S, Ishido K, Higuchi K, et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: A retrospective comparison with conventional endoscopic resection in a single center[J]. Gastric Cancer, 2014, 17(1): 130-136.
[1] 安杰, 牛云峰, 刘伟. LINC00520 通过miR-519b-3p/HIF1A 轴促进胃癌的侵袭转移[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 430-436.
[2] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[3] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[4] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[5] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[6] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[7] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[8] 杨建波, 马欢, 黄小梅, 刘华柱. 结肠镜辅助下EMR、CSP和RFA术治疗直径<1cm结直肠息肉的疗效和安全性比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 76-79.
[9] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[10] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[11] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[12] 刘海旺, 施海, 尚利峰. 不同吻合器在腹腔镜远端胃癌根治术Roux-en-Y式吻合中的应用对比[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 643-646.
[13] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[14] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[15] 张立俊, 孙存杰, 胡春峰, 孟冲, 张辉. MSCT、DCE-MRI 评估术前胃癌TNM 分期的准确性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 519-523.
阅读次数
全文


摘要